Element Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Sell
1,448
-4
-0.3% -$4.05K 0.55% 49
2025
Q4
$1.56M Buy
1,452
+90
+7% +$86.1K 0.64% 37
2025
Q3
$1.04M Buy
1,362
+3
+0.2% +$2.23K 0.45% 58
2025
Q2
$1.06M Buy
1,359
+900
+196% +$699K 0.49% 50
2025
Q1
$379K Sell
459
-20
-4% -$16.6K 0.2% 94
2024
Q4
$370K Buy
479
+4
+0.8% +$3.31K 0.19% 93
2024
Q3
$420K Sell
475
-68
-13% -$61.1K 0.22% 85
2024
Q2
$492K Hold
543
0.28% 68
2024
Q1
$423K Buy
543
+30
+6% +$21.4K 0.25% 77
2023
Q4
$299K Sell
513
-15
-3% -$8.76K 0.19% 98
2023
Q3
$283K Sell
528
-21
-4% -$10.8K 0.2% 94
2023
Q2
$258K Buy
+549
New +$230K 0.18% 100

Other funds holding LLY

Element Wealth's LLY Position: Q1 2026 in Review

Element Wealth reduced its Eli Lilly (LLY) stake by 0.28% in Q1 2026, selling an estimated $4.05K and leaving 1,448 shares worth $1.33M. The position accounts for 0.55% of the portfolio, ranked #49.

Element Wealth first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.56M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Element Wealth held 1,448 shares of Eli Lilly worth $1.33M as of Q1 2026.
  • Element Wealth sold 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 0.55% of Element Wealth's portfolio in Q1 2026, its #49 holding.
  • Element Wealth first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Element Wealth's Eli Lilly position peaked at $1.56M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Element Wealth's 13F filing for Q1 2026, filed 4 May 2026.